Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Change in Receivables (2016 - 2025)

InspireMD (NSPR) has 16 years of Change in Receivables data on record, last reported at -$21000.0 in Q3 2025.

  • For Q3 2025, Change in Receivables fell 109.42% year-over-year to -$21000.0; the TTM value through Sep 2025 reached -$165000.0, down 1600.0%, while the annual FY2024 figure was -$232000.0, 153.33% down from the prior year.
  • Change in Receivables reached -$21000.0 in Q3 2025 per NSPR's latest filing, up from -$194000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $339000.0 in Q2 2023 and bottomed at -$332000.0 in Q2 2024.
  • Average Change in Receivables over 5 years is -$9210.5, with a median of $8000.0 recorded in 2025.
  • The widest YoY moves for Change in Receivables: up 1560.0% in 2022, down 1066.67% in 2022.
  • A 5-year view of Change in Receivables shows it stood at $24000.0 in 2021, then crashed by 1066.67% to -$232000.0 in 2022, then skyrocketed by 222.84% to $285000.0 in 2023, then plummeted by 85.26% to $42000.0 in 2024, then crashed by 150.0% to -$21000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$21000.0 in Q3 2025, -$194000.0 in Q2 2025, and $8000.0 in Q1 2025.